We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Animalcare Group Plc (ANCR) Ordinary 20p

Sell:214.00p Buy:220.00p 0 Change: No change
Market closed Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:214.00p
Buy:220.00p
Change: No change
Market closed Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:214.00p
Buy:220.00p
Change: No change
Market closed Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Animalcare Group plc is a United Kingdom-based international veterinary sales and marketing company. The Company is focused on bringing products to market through its own development pipeline, partnerships and through acquisitions. The Company develops and commercializes prescription and over-the-counter pharmaceutical products that improve animal health and wellbeing. These are developed in-house, acquired from other companies or in-licensed from its partners. The Company manages an international supply chain, including specialist veterinary wholesalers and distributors. It partners with companies to commercialize products across Europe. The Company operates in three categories within the veterinary market: companion animals, equine and other, and production animals. Its product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs. The Company operates in seven countries and exports to about 40 countries in Europe and worldwide.

Contact details

Address:
Moorside, Monks Cross
YORK
YO32 9LB
United Kingdom
Telephone:
+44 (01904) 487687
Website:
https://www.animalcaregroup.com/

Important dates

Future events
Final ex-dividend date 20 June 2024 20/06/24
AGM 20 June 2024 20/06/24
Past events
Final results 09 April 2024 09/04/24
Trading Announcement 25 January 2024 25/01/24
Interim dividend payment date 17 November 2023 17/11/23
Interim ex-dividend date 19 October 2023 19/10/23
Interim results 26 September 2023 26/09/23
Trading Announcement 26 September 2023 26/09/23
Trading Announcement 27 July 2023 27/07/23
Final dividend payment date 14 July 2023 14/07/23
Final ex-dividend date 15 June 2023 15/06/23
AGM 13 June 2023 13/06/23
Annual report 19 May 2023 19/05/23

General stock information

EPIC:
ANCR
ISIN:
GB0032350695
Market cap:
£130.43 million
Shares in issue:
60.11 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Jennifer Winter
    Chief Executive Officer, Executive Director
  • Chris Brewster
    Chief Financial Officer, Executive Director, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.